---
title: Regulatory workshop on challenge strain development and GMP manufacture - A
  stakeholder meeting report
date: '2024-02-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38309984/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240204170643&v=2.18.0
source: heidelberg[Affiliation]
description: Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project,
  a regulatory workshop was organised on the development and manufacture of challenge
  agent strains for Controlled Human Infection Model (CHIM) studies. Developers are
  often uncertain about which GMP requirements or regulatory guidelines apply but
  should be guided by the 2022 technical white paper "Considerations on the Principles
  of Development and Manufacturing Qualities of Challenge Agents for Use in Human
  ...
disable_comments: true
---
Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project, a regulatory workshop was organised on the development and manufacture of challenge agent strains for Controlled Human Infection Model (CHIM) studies. Developers are often uncertain about which GMP requirements or regulatory guidelines apply but should be guided by the 2022 technical white paper "Considerations on the Principles of Development and Manufacturing Qualities of Challenge Agents for Use in Human ...